Cure8 research brief
PROM completion is important for monitoring symptoms and disease control between visits. The study shows a single empowerment campaign produced a short‑term boost in PROM response but not sustained engagement, highlighting the need for ongoing strategies—especially for patients with limited digital access.
Adult IBD patients (Crohn's disease and ulcerative colitis), IBD clinic nurses and physicians, and clinic managers responsible for PROM implementation and patient engagement.
The PROMOTION study sent PRO questionnaires (PRO‑2, IBD Disk, IBD Control) to 811 patients and analyzed response rates before and after a multi‑modal empowerment campaign. Overall response was 58.6%; there was a sharp early increase in the first month after the intervention (≈72% vs ≈58%) but no sustained improvement over six months.
Response rates were much higher for remote follow‑up than in‑person follow‑up, and PRO‑2 remission was reported among those who fully completed questionnaires.
Structured content depth: abstract — this note is grounded in the article abstract supplied by the journal. The study is single‑centre and measures response rates to PROM distribution and an empowerment campaign; it does not report randomized intervention effectiveness or long‑term clinical outcomes.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with IBD have a higher lifetime risk of colorectal cancer; updated UK guidelines give clinicians and patients evidence-based recommendations on when and how to do surveillance colonoscopy to detect precancerous...
A new CE-marked food-intolerance diagnostic could give people with Crohn’s or UC a non-invasive tool to explore dietary triggers alongside clinical care. Regulatory certification means the products met EU safety and...
IBD may involve small-vessel changes beyond the gut. If reproducible, retinal microvascular alterations detectable by OCTA could offer a non-invasive window into systemic microvascular involvement in IBD.
